Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Adocia    ADOC   FR0011184241

ADOCIA (ADOC)

Real-time Quote. Real-time Tradegate - 06/28 03:54:29 pm
20.5 EUR   -1.87%
04/18 ADOCIA : announces first quarter 2017 financial results
04/13ADOCIA SAS : quaterly sales release
03/02ADOCIA SAS : annual earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Adocia
Operates as a clinical-stage biotechnology company

Adocia SA operates as a clinical-stage biotechnology company, which engages in the development of medicines from already approved therapeutic agents.

Its product pipeline includes BioChaperone PDGF, which is in Phase III clinical trials for the treatment of diabetic foot ulcer; BioChaperone insulin that is in Phase I/II clinical trials, as well as in pre-clinical staged for the treatment of diabetes; and Driveln, which is in preclinical stage for the treatment of oncology.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.



Number of employees : 125 persons.
Sales per Businesses
20152016Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine36.94100%22.49100% -39.12%
Sales per Regions
20152016Delta
EUR (in Million)%EUR (in Million)%
France36.94100%22.49100% -39.12%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA692005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006Chief Financial Officer & Administrative Director
Olivier Soula PhD, MBA482005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA47-Director
Laurent Arthaud55-Director
Dominique Takizawa602011Independent Director
Ekaterina Smirnyagina, PhD502013Independent Director
Rémi Soula PhD, MBA-2005Director-Business Development
David Duracher, PhD--Director-Pharmaceutical Development
Géraldine Favre-Soula--Director-Human Resources Development Department
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 6,846,363 5,260,639 76.8% 760 0.0% 76.8%
Shareholders
NameEquities%
Gérard Soula PhD, MBA 898,463 13.1%
BPIFrance Investissement SAS 738,639 10.8%
La Société Hospitalière d'Assurances Mutuelles SA 320,000 4.66%
Rémi Soula PhD, MBA 300,490 4.38%
Olivier Soula PhD, MBA 297,490 4.34%
Norges Bank Investment Management 82,675 1.21%
ACG Management SAS 67,439 0.98%
Aviva Investors France SA 55,277 0.81%
CM-CIC Asset Management SA 50,080 0.73%
CPR Asset Management SA 46,761 0.68%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ADOCIA-65.75%163
AMGEN16.85%125 643
CELGENE CORPORATION13.05%102 171
GILEAD SCIENCES-1.34%92 320
REGENERON PHARMACEUTIC..40.54%53 371
VERTEX PHARMACEUTICALS75.42%32 187
ACTELION23.13%30 672
GENMAB24.13%13 287
TESARO INC4.87%7 597
EXELIXIS, INC.58.22%6 900
BIOVERATIV INC0.00%6 521
KITE PHARMA INC123.97%5 544
HUALAN BIOLOGICAL ENGI..--.--%5 048
TONGHUA DONGBAO PHARMA..-17.37%4 577
BLUEBIRD BIO INC80.06%4 378
CLOVIS ONCOLOGY INC102.52%4 334
NEUROCRINE BIOSCIENCES..17.73%4 013
PEPTIDREAM INC15.13%3 592
JUNO THERAPEUTICS INC55.65%3 113
INTERCEPT PHARMACEUTIC..21.76%3 051
BIOCON LTD4.68%3 003
Sector Bio Therapeutic Drugs
Adocia : Connections
Institut Mérieux SA
Lyon Pôle Bourse
Capricorn Venture Partners NV
Lyon Place Financière & Tertiaire
Platine Pharma Services SAS
BPIFrance Investissement SAS
iSTAR Medical SA
Elsalys Biotech SAS
Alizé Pharma SAS
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, Next Biotech, PEA, PEA-PME, Tech 40
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem